Figures & data
Notes: Lung tissues were collected and pulmonary vascular remodeling was estimated. (A) HE staining showed the wall thickness of pulmonary vessels in patients. (B) Immunohistochemistry staining (α-SMA) showed the muscularized vessels of pulmonary vessels in patients. (C and D) Histogram showed the results of wall thickness and muscularized vessel percentage in patients. (E and F) Protein levels (SDS-PAGE and histogram) of HIF-1α, α-SMA, NOR1, and cyclin D1 in peripheral lung tissues of different patients. *P<0.01 as compared with control. Control: n=15; hypoxemia: n=11.
Abbreviations: NOR1, neuron-derived orphan receptor 1; HE, hematoxylin and eosin; SDS-PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresis.
Abbreviations: NOR1, neuron-derived orphan receptor 1; HE, hematoxylin and eosin; SDS-PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresis.
Abbreviations: NOR1, neuron-derived orphan receptor 1; PASMC, pulmonary arterial smooth muscle cell; SDS-PAGE, sodium dedecyl sulfate–polyacrylamide gel electrophoresis.
Notes: Human PASMCs were transfected by NOR1-siRNA or NC-siRNA, and then treated with hypoxia (5% O2) or normoxia (21% O2). (A and B) NOR1 protein levels (SDS-PAGE and histogram) in PASMCs after different treatments. (C) BrdU incorporation showed the DNA synthesis in PASMCs after different treatments. (D) Histogram shows the results of BrdU incorporation. (E) Cell count shows proliferation in PASMCs after different treatments. #P<0.05 as compared with normoxia, *P<0.05 as compared with NC-siRNA (n=6).
Abbreviations: NC, negative control; NOR1, neuron-derived orphan receptor 1; PASMC, pulmonary arterial smooth muscle cell; SDS-PAGE, sodium dodecyl sulfate– polyacrylamide gel electrophoresis.
Abbreviations: NC, negative control; NOR1, neuron-derived orphan receptor 1; PASMC, pulmonary arterial smooth muscle cell; SDS-PAGE, sodium dodecyl sulfate– polyacrylamide gel electrophoresis.
Notes: PASMCs were transfected with NOR1 overexpression plasmid vector (pNOR1) or control plasmid (control) and then were subjected to hypoxia or normoxia. (A and B) NOR1 protein levels (SDS-PAGE and histogram) after different treatments. (C) BrdU incorporation showed the DNA synthesis in PASMCs after different treatments. (D) Cells under an optical microscope (200×) after different treatments. (E) Histogram shows the results of BrdU incorporation. (F) Results of cell counts in PASMCs after different treatments. #P<0.01 as compared with normoxia, *P<0.01 as compared with hypoxia (n=6).
Abbreviations: NOR1, neuron-derived orphan receptor 1; PASMC, pulmonary arterial smooth muscle cell; SDS-PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresis.
Abbreviations: NOR1, neuron-derived orphan receptor 1; PASMC, pulmonary arterial smooth muscle cell; SDS-PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresis.
Notes: PASMCs were cultured in hypoxia (5% O2) or normoxia (21% O2) after different treatments. (A and B) Cyclin D1 protein levels (SDS-PAGE and histogram) in PASMCs after transfection with NOR1 overexpression plasmid (pNOR1). (C and D) Cyclin D1 protein levels (SDS-PAGE and histogram) in PASMCs after transfection with NOR1-siRNA or NC-siRNA. (E) BrdU incorporation in hypoxic or normoxic cells after PD0332991 (a specific inhibitor of cyclin D1-CDK4/6 complex) treatment. (F) Histogram shows the results of BrdU incorporation. (G) Results of cell counts in hypoxic or normoxic cells after PD0332991 treatment. #P<0.05 as compared with control (or normoxia), *P<0.05 as compared with NC-siRNA, &P<0.05 as compared with DMSO (n=6).
Abbreviations: NC, negative control; NOR1, neuron-derived orphan receptor 1; PASMC, pulmonary arterial smooth muscle cell; SDS-PAGE, sodium dodecyl sulfate– polyacrylamide gel electrophoresis.
Abbreviations: NC, negative control; NOR1, neuron-derived orphan receptor 1; PASMC, pulmonary arterial smooth muscle cell; SDS-PAGE, sodium dodecyl sulfate– polyacrylamide gel electrophoresis.